GELTEQ LTD (GELS) Stock Fundamental Analysis

NASDAQ:GELS • AU0000218109

0.7443 USD
-0.02 (-2.17%)
Last: Feb 20, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

1

Taking everything into account, GELS scores 1 out of 10 in our fundamental rating. GELS was compared to 191 industry peers in the Pharmaceuticals industry. GELS may be in some trouble as it scores bad on both profitability and health. GELS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year GELS has reported negative net income.
  • GELS had a negative operating cash flow in the past year.
  • In the past 5 years GELS always reported negative net income.
  • GELS had a negative operating cash flow in each of the past 5 years.
GELS Yearly Net Income VS EBIT VS OCF VS FCFGELS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 -2M -4M -6M

1.2 Ratios

  • GELS has a Return On Assets of -30.94%. This is comparable to the rest of the industry: GELS outperforms 51.83% of its industry peers.
  • With a Return On Equity value of -42.05%, GELS perfoms like the industry average, outperforming 55.50% of the companies in the same industry.
Industry RankSector Rank
ROA -30.94%
ROE -42.05%
ROIC N/A
ROA(3y)-21.21%
ROA(5y)-16.14%
ROE(3y)-28.1%
ROE(5y)-20.64%
ROIC(3y)N/A
ROIC(5y)N/A
GELS Yearly ROA, ROE, ROICGELS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 -10 -20 -30 -40

1.3 Margins

  • GELS's Gross Margin of 30.36% is in line compared to the rest of the industry. GELS outperforms 57.07% of its industry peers.
  • GELS's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for GELS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 30.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.29%
GM growth 5YN/A
GELS Yearly Profit, Operating, Gross MarginsGELS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 0 -1K -2K -3K -4K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • GELS does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, GELS has more shares outstanding
  • GELS has a worse debt/assets ratio than last year.
GELS Yearly Shares OutstandingGELS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
GELS Yearly Total Debt VS Total AssetsGELS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 5M 10M 15M 20M

2.2 Solvency

  • GELS has an Altman-Z score of -0.96. This is a bad value and indicates that GELS is not financially healthy and even has some risk of bankruptcy.
  • GELS has a Altman-Z score (-0.96) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that GELS is not too dependend on debt financing.
  • The Debt to Equity ratio of GELS (0.00) is better than 61.78% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -0.96
ROIC/WACCN/A
WACC8.17%
GELS Yearly LT Debt VS Equity VS FCFGELS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 5M -5M 10M 15M 20M

2.3 Liquidity

  • A Current Ratio of 0.27 indicates that GELS may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.27, GELS is doing worse than 94.24% of the companies in the same industry.
  • A Quick Ratio of 0.27 indicates that GELS may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.27, GELS is doing worse than 92.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.27
GELS Yearly Current Assets VS Current LiabilitesGELS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 1M 2M 3M 4M 5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for GELS have decreased strongly by -87.41% in the last year.
  • GELS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.95% yearly.
EPS 1Y (TTM)-87.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-486.26%
Revenue 1Y (TTM)N/A
Revenue growth 3Y3.95%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GELS Yearly Revenue VS EstimatesGELS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2025 50K 100K 150K

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • GELS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GELS Price Earnings VS Forward Price EarningsGELS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GELS Per share dataGELS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • GELS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GELTEQ LTD

NASDAQ:GELS (2/20/2026, 8:00:01 PM)

0.7443

-0.02 (-2.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-17
Earnings (Next)06-22
Inst Owners0.88%
Inst Owner ChangeN/A
Ins Owners41.53%
Ins Owner ChangeN/A
Market Cap7.97M
Revenue(TTM)165.70K
Net Income(TTM)-6.65M
AnalystsN/A
Price TargetN/A
Short Float %2.31%
Short Ratio0.1
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 68.35
P/FCF N/A
P/OCF N/A
P/B 0.72
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.5
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.41
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS0.01
BVpS1.04
TBVpS-0.27
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.94%
ROE -42.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 30.36%
FCFM N/A
ROA(3y)-21.21%
ROA(5y)-16.14%
ROE(3y)-28.1%
ROE(5y)-20.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.29%
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 387.57%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.27
Quick Ratio 0.27
Altman-Z -0.96
F-Score4
WACC8.17%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-87.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-486.26%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3Y3.95%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-94.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-405.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-415.8%
OCF growth 3YN/A
OCF growth 5YN/A

GELTEQ LTD / GELS FAQ

Can you provide the ChartMill fundamental rating for GELTEQ LTD?

ChartMill assigns a fundamental rating of 1 / 10 to GELS.


What is the valuation status of GELTEQ LTD (GELS) stock?

ChartMill assigns a valuation rating of 0 / 10 to GELTEQ LTD (GELS). This can be considered as Overvalued.


Can you provide the profitability details for GELTEQ LTD?

GELTEQ LTD (GELS) has a profitability rating of 1 / 10.


Can you provide the financial health for GELS stock?

The financial health rating of GELTEQ LTD (GELS) is 1 / 10.